KCT0003187招募中未知
Safety and Efficacy of Intraperitoneal Paclitaxel in Gastric Cancer Patients with Peritoneal Metastasis receiving Systemic Chemotherapy
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 43
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 80(Year)（—）
- 性别
- All
入选标准
- •Adenocarcinoma of stomach by endoscopic biopsy, primary or recurrent
- •- Peritoneal carcinomatosis proved with CT or diagnostic laparoscopy
- •- Decided to use mFOLFOX-6 treatment in Multi-Disciplinary outpatient clinic
- •- No previous chemotherapy for gastric cancer, or 4 weeks after previous chemotherapy
- •- Adequate blood exam ( Within 2 weeks of treatment)
- •?Neutrophil ? 1,500/mm3??
- •?Hb ? 8.0g/dL
- •?Platelet? 10×104/mm3
- •?GOT /GPT ? 100U/L
- •?Total bilirubin? 2.0mg/dL
- •?Creatinine Clearance(CCl)? 50mL/min
- •- Performance status 0-2
- •- Her-2 negative
- •- Age between 20 to 80 years old
排除标准
- •- Accompanying severe medical disease or other malignancies
- •- Contraindication of using Fluorouracil, Oxaliplatin, Leucovorin or Paclitaxel
- •- Pregnant or currently breast feeding or possibility of pregnancy
- •- Rejection of treatment
研究者
相似试验
已完成
1 期
Exploratory study of intraperitoneal paclitaxel combined with mFOLFOX6 for gastric cancer patients with peritoneal metastasis and inadequate oral intakegastric cancer with peritoneal metastasisJPRN-UMIN000019206The University of Tokyo34
尚未招募
不适用
Treatment of abdominal mesothelioma with intra-abdominal chemotherapy - INTERACT MESONL-OMON26729one21
招募中
不适用
Intraperitoneal Paclitaxel for Patients with Primary Malignant Peritoneal Mesothelioma - a Phase I/II Dose Escalation and Safety StudyNL-OMON56619Erasmus MC, Universitair Medisch Centrum Rotterdam21
已完成
1 期
Phase I study of weekly intraperitoneal paclitaxel combined with oxaliplatin plus S-1 for advanced gastric cancer with peritoneal metastasisgastric cancer with peritoneal metastasisJPRN-UMIN000004978The University of Tokyo Hospital9
招募中
2 期
Intraperitoneal and intravenous paclitaxel plus S-1Gastric cancer with peritoneal metastasis or positive peritoneal cytology.JPRN-jRCTs061180008Fujiwara Yoshiyuki50